Genmab — Oktober 2016
-
Jeg tror mht biotech, så er markedet bange for at udover at Clinton bliver præsident, at demokraterne for flertal i kongressen. Dvs at Clinton derved for lettere ved at indføre en form for priskontrol på medicinske produkter
-
-
aftenkurser er som viden blæser fra bank til bank, og kan ikke bruges til at sige noget om morgendagensretning. Og dara har været tilgængeligt siden slut juli i dk, er tidligere publiceret i udbuds bekendtgørelse som mærkeligt nok J&J vandt uden konkurrence.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind